Founded in 2002, Sinocare has been dedicating to providing innovative, high-quality products and services to people with diabetes and other chronic diseases to improve their quality of life.
As of now, Sinocare has established a formidable presence with 9 global R&D and manufacturing sites, serving over 25 million users worldwide, with a business footprint in 187 countries and regions, with a dominant presence in the global blood glucose monitoring market, ranking first in China and fourth worldwide.


Sinocare actively promotes the synergistic development of human health and a green planet through technological innovation and humanistic care, as well as continuously invests in technological innovation and engages in medical public welfare activities. We aim to effectively reduce healthcare costs, make quality diabetes management services accessible and affordable, and create sustainable value for both users and society while realizing stable business growth.